ALX3 Full Name
aristaless-like homeobox 3
ALX3 Introduction
ALX3 encodes a paired-class homeodomain transcription factor that functions as a key regulator of craniofacial and limb development. Like its family members ALX1 and ALX4, ALX3 possesses a conserved 60-amino-acid helix-turn-helix homeodomain that mediates sequence-specific DNA binding. During embryogenesis, ALX3 is expressed in the frontonasal ectodermal zone (FEZ) and in the apical ectodermal ridge (AER) of developing limb buds, where it participates in the patterning of the midface, nose, and distal skeletal elements. Within the FEZ, ALX3 is induced by combinatorial signals from the BMP, Wnt, and fibroblast growth factor (FGF) pathways at the neural plate border, and it acts in concert with ALX1 to specify the identity and migration of frontonasal neural crest cells. Genetic ablation of ALX3 in mice results in subtle facial clefting and minor digit abnormalities, indicating a partially redundant role with other ALX family members, while its complete loss in humans causes a distinct craniofacial syndrome.
Figure 1. Lack of folic acid prevents expression of Alx3 and closure of cranial neural tube. (Source: Lakhwani S, et al. 2010)
Homozygous or compound heterozygous loss-of-function mutations in ALX3 are the primary cause of frontonasal dysplasia type 3, a syndrome that shares substantial phenotypic overlap with ALX1-related disease. The cardinal features include marked orbital hypertelorism, median cleft lip with or without cleft palate, basal encephalocele, and nasal anomalies including absence or hypoplasia of the nasal bones and septum. The similarity between ALX1- and ALX3-mutant phenotypes reflects their cooperative function in the FEZ, where they regulate partially overlapping sets of downstream target genes. Notably, the ALX3-associated FND3 phenotype is generally more variable and may be milder in individuals with mutations that partially preserve protein function, while complete loss-of-function alleles produce the full syndrome. In addition to FND3, ALX3 variants have been implicated in non-syndromic midfacial hypoplasia, highlighting the gene's dose-sensitive contribution to normal facial morphology.
Alternate Names for ALX3
ALX3
aristaless-like homeobox 3
homeobox protein aristaless-like 3
aristaless 3
